Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effect of Front-of-Package Labels on Intent to Purchase Packaged Foods in the Philippines

16 novembre 2026 mis à jour par: Johns Hopkins Bloomberg School of Public Health

Effect of Front-of-Package Labels on the Intent to Purchase Packaged Foods in the Philippines: A Five-Arm Randomized Controlled Trial

The Philippines is considering a mandatory front-of-package label (FoPL) for packaged foods. This randomized controlled trial will test which label design best helps consumers avoid products high in sugar, sodium, or saturated fat. Adults who buy packaged foods will be approached outside supermarkets and other food retailers in three locations: the City of Manila, Iloilo City, and the Municipality of San Jose, Dinagat Islands. After consent, each participant will be randomly assigned to one of five groups and will view mock packaged food products on a tablet: no label (control), a Nutrient Warning Label, a Multiple Traffic Light label, a Health Star Rating, or a Nutri-Grade style label. The main outcome is how likely participants say the participant is to buy products that contain nutrients of concern in excess. The study will also measure whether participants can correctly identify which nutrients are in excess, which of two similar products the participant would buy, and which product the participant thinks is healthier. Results will inform FoPL policy in the Philippines.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Intervention / Traitement

Description détaillée

This is a five-arm, parallel-group, individually randomized trial with a single study visit of about 25 minutes. Trained research assistants recruit participants using street-intercept methods outside food retailers, screen for eligibility, and obtain written informed consent. Participants are randomized 1:1:1:1:1 in REDCap, stratified by study site, using an allocation table generated by an independent statistician; the enumerator does not know the allocation sequence in advance.

Within the assigned arm, participants complete: (1) single-product tasks, in which the participant views one mock product at a time (product order randomized), rate the intent to purchase on a 7-point scale, and indicate whether the product contains sugar, sodium, saturated fat, or protein in excess (protein is a distractor and is never in excess); (2) paired-product comparison tasks, in which, for three pairs of similar products showing different versions of the same label system, the participant's choose which product the participant would buy, which is healthier, and which the participant would be more worried about a child consuming; and (3) label acceptability questions, a label comparison task, and demographic questions. The Pan American Health Organization (PAHO) Nutrient Profile Model is used as an independent standard to classify products as containing sugar, sodium, or saturated fat in excess.

Sample size: 2,105 participants (approximately 701 per site; 421 per arm). This provides 80% power to detect a 0.36-point difference in mean intent to purchase (SD 1.5) for each label versus no label (Bonferroni alpha = 0.0125) and for pairwise comparisons among effective labels (alpha = 0.0083).

Primary analysis: a linear model of each participant's mean purchase-intent score across four products, with treatment arm as a fixed effect and no label as the reference category (four primary contrasts), adjusting for pre-specified baseline covariates that are imbalanced across arms. Multiplicity is controlled using the Hochberg step-down procedure. If any label is effective compared with no label, effective labels are compared pairwise (up to six contrasts). Statisticians are blinded to arm assignment for the primary outcome analysis.

Type d'étude

Interventionnel

Inscription (Estimé)

2105

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Dinagat Islands
      • San Jose, Dinagat Islands, Philippines
        • Pas encore de recrutement
        • Municipality of San Jose, Dinagat Islands
    • Iloilo
      • Iloilo City, Iloilo, Philippines
        • Pas encore de recrutement
        • Iloilo City
    • National Capital Region
      • Manila, National Capital Region, Philippines
        • Recrutement
        • City of Manila

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 59 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Age 18 to 59 years
  • Purchases packaged foods
  • Resident of the Philippines
  • Able and willing to provide written informed consent

Exclusion Criteria:

  • Age under 18 or over 59 years
  • Does not purchase packaged foods
  • Not a resident of the Philippines
  • Adults lacking capacity to consent

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: No label (control)

Participants view mock packaged food products without any front-of-package label.

Expérimental: Nutrient Warning Label (NWL)

Mock packaged food products display black octagonal warning labels for each nutrient (sugar, sodium, saturated fat) present in excess.

Front-of-package warning symbols flagging each nutrient of concern (sugar, sodium, saturated fat) that exceeds the label's nutrient profile threshold, applied to mock packaged food images shown on a tablet during a single study visit.

Autres noms:
  • NWL
Expérimental: Multiple Traffic Light (MTL)

Mock packaged food products display a Multiple Traffic Light label with red, amber, or green color coding of sugar, sodium, and saturated fat levels.

Front-of-package label showing levels of sugar, sodium, and saturated fat color-coded red, amber, or green, applied to mock packaged food images shown on a tablet during a single study visit.

Autres noms:
  • MTL
Expérimental: Health Star Rating (HSR)

Mock packaged food products display a Health Star Rating summary score (0.5 to 5 stars).

Front-of-package summary rating from 0.5 to 5 stars based on an underlying nutrient profile algorithm, applied to mock packaged food images shown on a tablet during a single study visit.

Autres noms:
  • LGV
Expérimental: Nutri-Grade style (NG)

Mock packaged food products display a Nutri-Grade style letter-grade label.

Front-of-package letter-grade summary label (Nutri-Grade style), applied to mock packaged food images shown on a tablet during a single study visit.

Autres noms:
  • NG

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Mean Self-Reported Intent to Purchase Products Containing Nutrients of Concern in Excess
Délai: During the single study visit (Day 1, approximately 25 minutes)

After viewing each of four mock packaged products containing sugar, sodium, and/or saturated fat in excess (per the PAHO Nutrient Profile Model), participants answer: "Imagine you were looking to buy [product]. Would you buy this product for yourself or your family?" on a fully labeled 7-point scale (1 = I would certainly not buy this product; 4 = Neutral; 7 = I would definitely buy this product). The outcome is the participant's mean score across the four products (range 1-7; higher scores indicate greater intent to purchase). Each front-of-package label arm is compared with the no-label control.

During the single study visit (Day 1, approximately 25 minutes)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Accuracy in Identifying Nutrients of Concern Present in Excess
Délai: During the single study visit (Day 1)

For each single-product task, participants report whether the product contains sugar, sodium, saturated fat, and protein in excess (Yes / No / I don't know). Reported as the proportion of correct identifications (sensitivity and overall accuracy) per nutrient and pooled across products, compared between each label arm and no label and among effective labels. "I don't know" is counted as incorrect. Protein is never in excess; the false-positive rate for protein is also reported.

During the single study visit (Day 1)
Selection of the Healthier Product for Purchase in Paired Product Comparisons
Délai: During the single study visit (Day 1)

For each of three pairs of similar products showing different versions of the assigned label system (e.g., fewer vs. more warnings), participants choose which product the participant would buy (Product A / Product B / Either / Neither). Outcome: selection of the healthier product (1) vs. any other response (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

During the single study visit (Day 1)
Correct Identification of the Healthier Product in Paired Product Comparisons
Délai: During the single study visit (Day 1)

For each of three product pairs, participants choose which product is healthier (Product A / Product B / I don't know). Outcome: correct choice (1) vs. incorrect choice or "I don't know" (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

During the single study visit (Day 1)
Concern About Child Consumption in Paired Product Comparisons (proportion of participants selecting the less healthful product)
Délai: During the single study visit (Day 1)

For each of three product pairs, participants choose which product the participant would be more worried about letting a child consume (Product A / Product B / I don't know). Reported as the proportion selecting the less healthful product, by arm.

During the single study visit (Day 1)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Collaborateurs

Les enquêteurs

  • Chercheur principal: Megan E Henry, PhD, Johns Hopkins Bloomberg School of Public Health
  • Chercheur principal: TJ Robinson Moncatar, RN, MPH, PhD, University of the Philippines Manila, College of Public Health

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

15 novembre 2026

Achèvement primaire (Estimé)

1 décembre 2026

Achèvement de l'étude (Estimé)

1 juin 2027

Dates d'inscription aux études

Première soumission

16 novembre 2026

Première soumission répondant aux critères de contrôle qualité

16 novembre 2026

Première publication (Réel)

20 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

20 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

16 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • IRB00033681
  • 90104337 (Autre subvention/numéro de financement: Resolve to Save Lives)
  • UPMREB 2026-0392-01 (Autre identifiant: University of the Philippines Manila Research Ethics Board)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Under the Institutional Review Board (IRB) approved data management plan, individual participant data will not be shared with investigators outside the study team.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .